Literature DB >> 9291863

Severe juvenile dermatomyositis complicated by pancreatitis.

Y See1, K Martin, M Rooney, P Woo.   

Abstract

We report two boys with juvenile dermatomyositis (JDM) complicated by pancreatitis. One also had hepatitis and probably mild bowel vasculitis, while the other had catastrophic bowel vasculitis with multiple perforations. Both were on corticosteroids, but had features of active vasculitis. The former improved with high-dose i.v. pulsed methylprednisolone, while the latter improved only after immunosuppression with i.v. methylprednisolone, cyclophosphamide and plasmapheresis. Although bowel vasculitis is a known complication of severe JDM, pancreatitis and hepatitis are extremely rare. We have found in a literature search only three other reports of pancreatitis complicating JDM. We wish to alert physicians that pancreatitis may develop in JDM. It should be considered as a differential diagnosis in the child with active disease who develops abdominal pain. Control of vasculitis with adequate immunosuppression, as well as general supportive measures, may be valuable in the treatment of pancreatitis in JDM.

Entities:  

Mesh:

Year:  1997        PMID: 9291863     DOI: 10.1093/rheumatology/36.8.912

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  10 in total

Review 1.  The use of immunosuppressive and cytotoxic drugs in non-malignant disease.

Authors:  P A Brogan; M J Dillon
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

Review 2.  Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis.

Authors:  Theonymfi Doudouliaki; Charalampia Papadopoulou; Claire T Deakin
Journal:  Curr Rheumatol Rep       Date:  2021-03-08       Impact factor: 4.592

3.  Acute acalculous cholecystitis in a patient with juvenile dermatomyositis.

Authors:  Bruno Fernandes Sanches; Teresa Martins; Maria José Santos; Paula Azeredo
Journal:  BMJ Case Rep       Date:  2014-09-19

Review 4.  Treatment of Calcinosis in Juvenile Dermatomyositis.

Authors:  Ovgu Kul Cinar; Charalampia Papadopoulou; Clarissa A Pilkington
Journal:  Curr Rheumatol Rep       Date:  2021-02-08       Impact factor: 4.592

Review 5.  [Dermatomyositis and juvenile dermatomyositis].

Authors:  Frank Dressler; Britta Maurer
Journal:  Z Rheumatol       Date:  2022-04-29       Impact factor: 1.372

Review 6.  Vasculitis from the pediatric perspective.

Authors:  P A Brogan; M J Dillon
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.686

7.  Unilateral heliotrope rash in juvenile dermatomyositis: an unusual presentation of an underlying serious disease.

Authors:  Ghada Al-Janobi; Hisham Alkhalidi; Mohammed A Omair
Journal:  Case Rep Rheumatol       Date:  2014-12-22

8.  An Autopsy Case of a 5-Year-Old Child with Acute Pancreatitis Caused by Eosinophilic Granulomatosis with Polyangiitis-like Necrotizing Vasculitis.

Authors:  Haruna Yagi; Seishiro Takahashi; Tetsuo Kibe; Kenji Shirai; Isao Kosugi; Hideya Kawasaki; Shiori Meguro; Toshihide Iwashita; Hiroshi Ogawa
Journal:  Case Rep Rheumatol       Date:  2019-09-02

9.  Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.

Authors:  Yingjie Xu; Xiaolin Ma; Zhixuan Zhou; Jianguo Li; Jun Hou; Jia Zhu; Min Kang; Jianming Lai; Xiaohui Li
Journal:  Pediatr Rheumatol Online J       Date:  2021-01-06       Impact factor: 3.054

10.  Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.

Authors:  Claire T Deakin; Raquel Campanilho-Marques; Stefania Simou; Elena Moraitis; Lucy R Wedderburn; Eleanor Pullenayegum; Clarissa A Pilkington
Journal:  Arthritis Rheumatol       Date:  2018-03-25       Impact factor: 10.995

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.